SCHEMBL14685191

SCHEMBL14685191

CC(C)OCCOc1ccc(C(C)(C)CC(C)(C)C)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.64
▸ SMN1; SMN2 Q16637 3/20 0.64
▸ HIF1A Q16665 4/20 0.49
▸ HRH3 Q9Y5N1 4/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ APAF1 O14727 2/20 0.49
▸ USP2 O75604 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ ERBB2 P04626 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ FYN P06241 2/20 0.49
▸ CHRM2 P08172 2/20 0.49
▸ CHRM4 P08173 2/20 0.49
▸ CHRM5 P08912 2/20 0.49
▸ ADRA2A P08913 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ HSPD1 P10809 2/20 0.49
▸ CHRM1 P11229 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9632640 0.88 CYP3A4 (0.60) CYP3A4SMN1; SMN2HIF1AHRH3MEN1
SCHEMBL29167471 0.88 CYP3A4 (0.60) CYP3A4SMN1; SMN2HIF1AHRH3MEN1
SCHEMBL28121417 0.88 SMN1; SMN2 (0.65) CYP3A4SMN1; SMN2HIF1AHRH3MEN1
SCHEMBL13484319 0.85 HRH3 (0.52) HRH3ALDH1A1MAPTMAOB
SCHEMBL8679414 0.85 CYP3A4 (0.57) CYP3A4SMN1; SMN2HIF1AHRH3MEN1
Hydrochloric Acid SCHEMBL27231886 0.85 SMN1; SMN2 (0.57) CYP3A4SMN1; SMN2HIF1AHRH3MEN1
Hydrochloric Acid SCHEMBL26134088 0.84 SMN1; SMN2 (0.56) CYP3A4SMN1; SMN2HIF1AHRH3MEN1
SCHEMBL13483901 0.83 KMT2A (0.50) CYP3A4SMN1; SMN2HRH3MEN1KMT2A
SCHEMBL74884 0.83 SMN1; SMN2 (0.51) CYP3A4SMN1; SMN2HIF1AMEN1KMT2A
Potassium Ion SCHEMBL4542321 0.82 CYP3A4 (0.54) CYP3A4SMN1; SMN2HIF1AHRH3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150366966-A1 Stable Aqueous Solution SENJU PHARMACEUTICAL CO., LTD. (JP) 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366966-A1 Stable Aqueous Solution CEL, TBCA, LIPA CYP3A4 769/4885SMN1; SMN2 293/4885HIF1A 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback